echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Shortage of medicines, urgent clinical needs, medicines for children!

    Shortage of medicines, urgent clinical needs, medicines for children!

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In the past two days, CDE has successively included 7 varieties of 16 listing applications with acceptance numbers for priority revi.


    From: CDE official website

    National Drug Shortage Drug List Varieties

    National Drug Shortage Drug List Varieties

    Drug name: Neostigmine methyl sulfate injection;

    Drug Name:

    Company name: Chengdu Yuandong Biopharmaceutical .


    Company Name:

    Proposed indications (or functional indications): (1) For myasthenia gravis, respiratory depression caused by curare (tubocurarine), postoperative or postpartum intestinal paralysis, gastrointestinal dysfunction, dysuria, e.


    Proposed indications (or functional indications):

    From: CDE official website

    Neostigmine is an anticholinesterase drug developed by Shionogi .


    Distribution of R&D Progress of Neostigmine Injection by Domestic Enterprises

    From: Insight database (http://.


    Drug name: methotrexate injection (pre-filled)

    Drug Name:

    Company name: Shenzhen Kangzhe Biotechnology .


    Company Name:

    Intended Indication (or Functional Indication): For the treatment of severe, intractable, disabling psoriasis that is insensitive to conventional thera.


    Proposed indications (or functional indications):

    From: CDE official website

    Methotrexate Injection (Prefilled) is a low-dose methotrexate (MTX) injection in a variety of strengt.


    According to the Insight database, in addition to this indication, CMS is also exploring other indications for methotrexa.


    Varieties of medicines for children

    Varieties of medicines for children

    Drug name: digoxin injection;

    Drug Name:

    Company name: Chengdu Better Pharmaceutical .


    Company Name:

    Proposed indications (or functional indications): 1) Adult heart failure: Digoxin injection is suitable for adults with mild to moderate heart failure, which can increase left ventricular ejection fraction, improve symptoms of heart failure, and improve exercise capaci.


    Proposed indications (or functional indications):

    From: CDE official website

    Digoxin is a commonly used cardiac glycoside drug, which can slow down the heart rate, effectively improve the symptoms of heart failure and cardiac function, reduce the hospitalization rate and shorten the hospitalization time of patients with severe congestive heart failu.


    Drug Name: Stiripentol Dry Suspension

    Drug Name:

    Company name: Shijiazhuang Four Medicine .


    Company Name:

    Intended Indication (or Functional Indication): In combination with clobazam and valproate, clobazam and valproate during seizures in patients with severe myoclonic epilepsy in infants (SMEI, Dravet syndrome) Adjunctive treatment of refractory generalized tonic-clonic seizures that are not adequately controll.


    Proposed indications (or functional indications):

    From: CDE official website

    Stiripentol received orphan drug designation in the European Union in 2001, followed by approval in the European Union in 2007 and in Japan and Canada in 2012 in combination with clobazam and valproate for severe myoclonus in infancy Adjuvant treatment of refractory generalized tonic-clonic seizures in patients with epilepsy (SMEI, Dravet syndrom.


    According to the Insight database, there are currently 3 domestic companies developing tipentanol suspensions, namely Shijiazhuang .


    Domestic layout of tiamyl alcohol enterprises

    From: Insight database (http://.

    d.

    cn/v5/home/)

    Drug Name: Clobazam Tablets

    Drug Name:

    Company name: Yichang Renfu Pharmaceutical .

    , L.

    ;

    Company Name:

    Intended Indication (or Functional Indication): Combination therapy for seizures in patients with Lennox-Gastaut syndrome (LGS) 2 years of age and old.

    Proposed indications (or functional indications):

    From: CDE official website

    Clobazam is a rare disease drug for children with refractory epilep.

    It was first approved for marketing in Australia in February 1970, and has been approved for marketing in more than 100 countries and regio.

    As a new type of adjuvant therapy for LGS, compared with traditional 1,4-benzodiazepines, it has the characteristics of definite curative effect, high safety and good tolerability, and will become a new drug for doctors to treat patients with LGS including L.

    A new option for intractable epilep.

    According to the Insight database, there is currently no such active ingredient approved for listing in China, and this application is the first in Chi.

    In addition to Yichang Renfu Pharmaceutical, Jinan Kehui Pharmaceutical Technology is developing the drug, which was approved for clinical use for the first time in March 201

    The current situation of domestic enterprises' layout of clobazam

    From: Insight database (http://.

    d.

    cn/v5/home/)

    Drug name: Kaglutamic acid dispersible tablets

    Drug Name:

    Company name: Ruikangdi (Beijing) Pharmaceutical .

    , L.

    Company Name:

    Proposed indications (or functional indications): This product is used to treat hyperammonemia caused by primary deficiency of N-acetylglutamate synthase (NAGS) in adults and children, and isovaleric acidemia (IVA) ), hyperammonemia caused by methylmalonic acidemia (MMA), hyperammonemia caused by propionic acidemia (P.

    Proposed indications (or functional indications):

    From: CDE official website

    Kaglutamate is a rare disease drug, initially approved overseas for hyperammonemia caused by N-acetylglutamate synthase (NAGS) deficiency, and the first FDA-approved drug for the treatment of patients with .

    or drugs for acute hyperammonemia caused by M.

    According to the Insight database, Kaglutamic acid has not been approved for listing in China at present, and this application is planned to be included in the priority review, which will also accelerate the domestic listing process of Kaglutamic ac.

    Domestic enterprise Kaglutamic acid research project

    From: Insight database (http://.

    d.

    cn/v5/home/)

    Clinically urgently needed varieties

    Clinically urgently needed varieties

    Drug Name: Sodium Thiosulfate Injection

    Drug Name:

    Company name: Sichuan Huiyu Pharmaceutical .

    , L.

    Company Name:

    Proposed indications (or functional indications): This product is mainly used for cyanide poisoning, and can also be used for arsenic, mercury, lead, bismuth, iodine and other poisoni.

    Proposed indications (or functional indications):

    From: CDE official website

    Sodium thiosulfate injection is a product on the national shortage li.

    According to the Insight database, only 5 domestic companies are currently developing sodium thiosulfate injection (including sodium thiosulfate injection and sodium thiosulfate for injectio.

    4 companies have been approv.

    Layout of domestic enterprises of sodium thiosulfate

    From: Insight database (http://.

    d.

    cn/v5/home/)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.